UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-KSB

                                   (Mark One)

         [X]      Annual report under Section 13 or 15(d) of the Securities
                  Exchange Act of 1934

         For the fiscal year ended January 31, 2004

         [ ]      Transition report under Section 13 or 15(d) of the Securities
                  Exchange Act of 1934

         For the transition period from _________ to _________

                         Commission File No. 333-103083

                              USED KAR PARTS, INC.
                 ----------------------------------------------
                 (Name of Small Business Issuer in Its Charter)

              Florida                                         04-3721895
- --------------------------------                         ----------------------
(State or Other Jurisdiction of                              (IRS Employer
 Incorporation or Organization)                          Identification Number)

 3 West 57th Street, New York, New York                          10019
- ----------------------------------------                       -----------
(Address of Principal Executive Offices)                       (Zip Code)


                                 (646) 442-4985
                           --------------------------
                           (Issuer's Telephone Number)

SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:  (None)

SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:  (None)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports); and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Check if there is no disclosure of delinquent filers pursuant to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [X]

State issuer's revenues for its most recent fiscal year. $0

The market value of the common stock held by non-affiliates cannot be estimated
since there is no market for the company's shares.

There were 2,068,000 shares of common stock outstanding as of May 5, 2004.

DOCUMENTS INCORPORATED BY REFERENCE None. Transitional Small Business Disclosure Format (check one): Yes [ ] No [X] 2

INTRODUCTORY NOTE This Annual Report on Form 10-KSB may be deemed to contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties set forth under "Risk Factors." Accordingly, to the extent that this Annual Report contains forward-looking statements regarding possible acquisitions, financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company's actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements. 3

PART I ITEM 1. DESCRIPTION OF BUSINESS THE COMPANY We were incorporated in the State of Florida on April 26, 2002 and planned to develop an on-line marketplace for used car parts. In an effort to develop that business, we entered into a contract with a web hosting service on a month to month basis to provide storage for website development and transaction processing. Our temporary website arrangement was suspended to preserve cash and pending new management's evaluation of the business. On February 24, 2004, Jeannine Karklins, formerly our President, Treasurer, Secretary and principal shareholder entered into a Capital Stock Purchase Agreement (the "Stock Purchase Agreement") with Panetta Partners, Ltd., a Colorado limited partnership ("Panetta"). All conditions to the closing were fulfilled and funds released to Ms. Karklins on February 26, 2004. Under the Stock Purchase Agreement: o Panetta purchased an aggregate of 2,000,000 restricted shares of our common stock from Ms. Karklins for $386,400 o Ms. Karklins resigned as an officer and director of the Company. The 2,000,000 shares represent approximately 97% of our outstanding shares of common stock. Of the $386,400 purchase price, $295,000 was borrowed from a private investor in technology companies based in the United Kingdom, and the balance came from the working capital of Panetta and its limited partners. The loan is due February 28, 2005, bears annual interest at 2% and is secured by a pledge of 1,520,000 of the 2,000,000 shares of the registrant's common stock acquired by Panetta. Panetta, acting in its capacity as our principal stockholder, appointed Christoph Bruening to serve as sole director, filling the vacancy created by the resignation of Ms. Karklins. Mr. Bruening also became President, Secretary and Treasurer. Panetta Partners, our principal stockholder entered into a letter of intent with a biotechnology company which contemplates the acquisition and financing of the biotechnology company. We are negotiating an acquisition agreement with the biotechology company. If we reach an agreement, we will promptly disclose the terms of the agreement and other information concerning the biotechnology company by filing a Form 8-K, including a copy of the agreement as an exhibit. The letter of intent provides for confidentiality and sets forth proposed terms, but is not a binding agreement to make the acquisition. Such an acquisition, if we can reach an agreement, will require the issuance of a substantial number of shares of our common stock, to the current shareholders of the biotech company in exchange for 100% of their outstanding stock and to investors to raise working capital. Our offices are located at 3 West 57th Street, New York, New York 10019. Our telephone number is (646) 442-4985. 4

We presently do not have a corporate Internet website. Our annual report on Form 10-KSB, quarterly reports on Form 10-QSB, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 15(d) of the Securities Exchange Act of 1934, as amended, are available on the website of the Securities and Exchange Commission at www.sec.gov shortly after they are filed or furnished. CORPORATE EMPLOYEES As of January 31, 2004, we had no employees. Our sole director and executive officer, Christoph Bruening, serves without compensation. RISK FACTORS Since our plan to develop an on-line market for used car parts did not result in any revenue and we are exploring acquisition opportunities, there are many risks and uncertainties that could impact our financial position or results of operations. No existing market Quotations for our common stock can be found on the Over The Counter Bulletin Board under the symbol "UKAR.OB" and our stock has not traded. Except for the OTC Bulletin Board, there is no existing trading market for our securities. Accordingly, there can be no assurance as to the liquidity of any markets that may develop for the securities, the ability of holders of the securities to sell their securities, or the prices at which holders may be able to sell their securities. The market price of our common stock may be adversely affected by several factors The market price of our common stock, if a market develops, could fluctuate significantly in response to various factors and events, including: o our ability to integrate operations, technology, products and services; o ability of a potential acquisition to execute their business plan; o operating results below expectations; o announcements of technological innovations or new products by us or our competitors; o loss of any strategic relationship; o industry developments; o economic and other external factors; and o period-to-period fluctuations in our financial results. In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock. Past stock performance is not an indication of future performance. 5

We will require additional funding to execute a business strategy of any company we may acquire or any business we develop. If funding is not available or not available on acceptable terms, we may be required to curtail our activities. We will require substantial additional funds to fund the development of a business. Our future capital requirements will depend on many factors. If we are able to reach an agreement with the biotechnology company with which we have a letter of intent, such factors will include continued scientific progress, progress with pre-clinical testing and clinical trials, the time and costs involved in obtaining regulatory approvals, the costs involved in filing, prosecuting and enforcing patent claims, competing technological and market developments, our ability to establish collaborative arrangements, effective commercialization activities and arrangements and the purchase or development of additional equipment and facilities. There can be no assurance that additional financing will be available, or, if available, that such additional financing will be available on terms acceptable to us. If additional funds are raised by issuing debt, we will incur fixed payment obligations, which could delay the time, if any, when we may achieve profitability. If adequate funds are not available, we may be required to delay, scale back or eliminate any business plans. ITEM 2. DESCRIPTION OF PROPERTY Panetta Partners, our principal stockholder, provides us with an office located in its offices at 3 West 57th Street, New York, New York and does not charge us rent. The facilities there are adequate for our limited current operations. In the event we acquire or develop a business we may require additional office or operating facilities. ITEM 3. LEGAL PROCEEDINGS We may from time to time be involved in various claims, lawsuits, disputes with third parties, actions involving allegations of discrimination, or breach of contract actions incidental to the operation of our business. We are not currently involved in any such litigation that we believe could have a materially adverse effect on our reported financial condition or results of operations. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS There were no matters submitted to a vote of security holders during the three months ended January 31, 2004. 6

PART II ITEM 5. MARKET FOR THE REGISTRANT'S COMMON STOCK AND RELATED SHAREHOLDER MATTERS MARKET INFORMATION Our securities do not currently, and have not in the past, traded on any public market. Thus, there is currently no market for our securities and there can be no assurance that a trading market will develop or, if one develops, that it will continue. The shares of commons tock are quoted in the NASD's OTC Bulletin Board under the symbol "UKAR.OB" NUMBER OF SHAREHOLDERS The number of shareholders of record of our Common Stock as of the close of business on May 5, 2004 was 52. DIVIDEND POLICY To date, we have declared no cash dividends on our Common Stock, and we do not expect to pay cash dividends in the near term. We intend to retain future earnings, if any, to provide funds for operation of our business. RECENT SALES OF UNREGISTERED SECURITIES We did not sell any securities during the three months ended January 31, 2004. ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION Critical Accounting Policies Our accounting policies are described in Note 1 of the consolidated financial statements included in this Annual Report on Form 10-KSB for the fiscal year ended January 31, 2004. The financial statements are prepared in accordance with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Since we are in the development stage and have had only limited expenditures and no estimates we do not consider any accounting policy to be critical to the understanding of our business. 7

Results of Operations Our audited financial statements, which are set forth in Item 7 of this report, reflect our operating results from April 26, 2002 (inception) to January 31, 2004 and for the year ended January 31, 2004. During the period from inception to January 31, 2004, we had no revenue and our expenses totaled $5,194, of which $1,024 was incurred in the fiscal year ended January 31, 2003 and $3,760 in the fiscal year ended January 31, 2004. Substantially all of these expenses were for office and administrative activities related to the early stages of developing plans for our on-line used car parts. We entered into an agreement for the hosting of our website prior to our change in control in February, 2004 and thereafter suspended that agreement to preserve cash pending our new management's assessment of plans. Substantially all of these expenditures were made by management before February, 2004. Panetta Partners, Ltd, our principal shareholder, pays for expenses such as accounting and legal fees relating to our reporting responsibility under the Securities Exchange Act of 1934, as well as provides us with an office location without any expectation of repayment. In the event we do not reach an agreement with the company with which we have a letter of intent or the transaction is not completed and we do not abandon our plan to develop on-line used car marketplace, we will incur expenses in this endeavor. Liquidity and Capital Resources Most of our operating expenses are borne by Panetta Partners, our principal shareholder, without any expectation of reimbursement. If the proposed acquisition is completed, we will require substantial additional funds to conduct and sponsor research and development activities, to conduct pre-clinical and clinical testing, and to market the target company's products. Our future capital requirements will depend on many factors, including continued scientific progress, progress with pre-clinical testing and clinical trials, the time and costs involved in obtaining regulatory approvals, the costs involved in filing, prosecuting and enforcing patent claims, competing technological and market developments, our ability to establish collaborative arrangements, effective commercialization activities and arrangements and the purchase or development of additional equipment and facilities. We will need to raise additional funds as a condition of closing. We intend to seek such additional funding through private financings. There can be no assurance that additional financing will be available, or, if available, that such additional financing will be available on terms acceptable to us. If additional funds are raised by issuing debt, we will incur fixed payment obligations, which could delay the time, if any, when we may achieve profitability. If adequate funds are not available, we may be required to delay, scale back or eliminate one or more of its principal product candidates or obtain funds through arrangements with collaborative partners or others that may require us to relinquish rights to certain of its technologies, product candidates or products that our prospective acquisition would not otherwise relinquish. ITEM 7. FINANCIAL STATEMENTS Our audited financial statements follow on the next page. 8

USED KAR PARTS, INC (A Development Stage Company) Audited Financial Statements April 26, 2002 (Inception) to January 31, 2004 TABLE OF CONTENTS Page ---- Independent Auditors' Report F-1 Balance Sheet F-2 Statements of Operations F-3 Statements of Changes In Stockholders' Equity F-4 Statements of Cash Flows F-5 Notes to Financial Statements F-6-F-7 9

BAUM & COMPANY, P.A. Certified Public Accountants 1515 University Drive - Suite 209 Coral Springs, Florida 33071 INDEPENDENT AUDITORS' REPORT The Board of Directors Used Kar Parts, Inc. New York City, New York We have audited the accompanying balance sheet of Used Kar Parts, Inc. (A Development Stage Company) as of January 31, 2004 and 2003 and the related statement of operations, cash flows and changes in stockholders' equity for the year ended January 31, 2004 and the period commencing April 26, 2002 (date of inception) to January 31, 2003. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audits in accordance with auditing standards generally accepted in the United States of America.. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, the financial statements present fairly, in all material respects, the financial position of Used Kar Parts, Inc.. (A Development Stage Company) at January 31, 2004 and 2003 and the statement of operations, cash flows and changes in stockholders' equity for the year ended January 31, 2004 and the period commencing April 26, 2002 (Date of Inception) to January 31, 2003 in conformity with accounting principles generally accepted in the United States of America. /s/ Baum & Company, P.A. Coral Springs, Florida May 14, 2004 F-1

USED KAR PARTS, INC. (A DEVELOPMENT STAGE COMPANY) BALANCE SHEETS JANUARY 31, 2004 AND 2003 ASSETS 2004 2003 --------- --------- Current Assets Cash $ 206 $ 3,876 --------- --------- Total Assets $ 206 $ 3,876 ========= ========= LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities $ - 0 - $ - 0 - --------- --------- Stockholders' Equity Common Stock, $.001 par value, authorized 50,000,000 shares, 2,068,000 issued and outstanding 2,068 2,068 Additional paid-in capital 3,332 3,332 Accumulated deficit during development stage (5,194) (1,524) Total Stockholders'Equity $ 206 $ 3,876 Total Liabilities and Stockholders' Equity $ 206 $ 3,876 ========= ========= See accompanying notes to financial statements. F-2

USED KAR PARTS, INC. (A DEVELOPMENT STAGE COMPANY) STATEMENTS OF OPERATIONS YEAR ENDED JANUARY 31, 2004 AND THE PERIOD COMMENCING APRIL 26, 2002 (DATE OF INCEPTION) TO JANUARY 31, 2003 Operations During Development Stage Inception April 26, 2002 2004 2003 To January 31, 2004 ----------- ----------- ------------------- Revenue $ - 0 - $ - 0 - $ - 0 - Operating expenses 3,670 1,524 5,194 ----------- ----------- ----------- Net income (loss) $ (3,670) $ (1,524) $ (5,194) =========== =========== =========== Weighed average of shares outstanding 2,068,000 229,778 =========== =========== Net income(loss) per share - basic and diluted $ (0.00) $ (0.01) =========== =========== See accompanying notes to financial statements. F-3

USED KAR PARTS, INC. (A DEVELOPMENT STAGE COMPANY) STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY PERIOD COMMENCING APRIL 26, 2002 (DATE OF INCEPTION) TO JANUARY 31, 2004 Common Stock Additional Deficit Total ------------------------- Paid-In Development Stage Stockholders' Shares Amount Capital Period Equity --------- ---------- ----------- ----------------- ------------- Beginning Balance April 26, 2002 (Inception) - 0 - $ - 0 - $ - 0 - $ - 0 - $ - 0 - Sale of common stock to to founder at par value 2,000,000 2,000 - 0 - 2,000 Sale of common stock for cash 68,000 68 3,332 - 0 - 3,400 Net (loss) - from inception through January 31, 2003 - 0 - - 0 - - 0 - (1,524) (1,524) --------- ---------- ---------- ---------- ---------- Balance - January 31, 2003 2,068,000 $ 2,068 $ 3,332 $ (1,524) $ 3,876 Net (loss) - January 31, 2004 - 0 - - 0 - - 0 - (3,670) (3,670) --------- ---------- ---------- ---------- ---------- Balance - January 31, 2004 2,068,000 $ 2,068 $ 3,332 $ (5,194) $ 206 ========= ========== ========== ========== ========== See accompanying notes to financial statements. F-4

USED KAR PARTS, INC (A DEVELOPMENT STAGE COMPANY) STATEMENTS OF CASH FLOWS YEAR ENDED JANUARY 31, 2004 AND THE PERIOD COMMENCING APRIL 26, 2002 (DATE OF INCEPTION) TO JANUARY 31, 2004 Operations During Development Stage Inception to 2004 2003 January 31, 2004 --------- --------- ------------------ Cash flows from operations: Net income (loss) $ (3,670) $ (1,524) $ (5,194) --------- --------- --------- Net cash provided (used) for operations (3,670) (1,524) (5,194) Cash flows from financing activities: Sale of common stock - 0 - 3,400 5,400 --------- --------- --------- Net increase (decrease) in cash (3,670) 3,876 206 Cash - beginning 3,876 - 0 - - 0 - --------- --------- --------- Cash - ending $ 206 $ 3,876 $ 206 ========= ========= ========= See accompanying notes to financial statements. F-5

USED KAR PARTS,INC.. (A DEVELOPMENT STAGE COMPANY) NOTES TO FINANCIAL STATEMENTS JANUARY 31, 2004 NOTE 1 SIGNIFICANT ACCOUNTING POLICIES Organization and Operations The Company was organized under the laws of the State of Florida on April 26, 2002. The Company is in the development stage. The Company plans to develop a website where individuals subscribe to and interact in an online marketplace for used car parts. The Company currently has no operations. On February 24, 2004, the principal stockholder and founder of the Company sold her controlling interest. Basis of Accounting The Company's policy is to prepare its financial statements using the accrual basis of accounting in accordance with generally accepted accounting principles. The Company has elected to use January 31 as its annual year end. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and equivalents Cash and cash equivalents include cash and cash in banks. The Company maintaines cash and cash equivalent balances at a financial institution that is insured by the Federal Deposit Insurance Corporation up to $100,000. At January 31, 2004, there is no concentration of credit risk from uninsured bank balances NOTE 2 CAPITAL TRANSACTIONS The Company sold 2,000,000 restricted shares of common stock to its founder in January, 2003 for $2,000. The Company in January, 2003 sold 68,000 restricted shares of common stock for $ .05 per share. The offering was made in reliance upon exemption from registration provided by Regulation D, Rule 504 of the Securities Exchange Commission. F-6

USED KAR PARTS, INC. (A DEVELOPMENT STAGE COMPANY) NOTES TO FINANCIAL STATEMENTS JANUARY 31, 2004 NOTE 4 INCOME TAX In February 1992, the Financial Standards Board issued Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes". Under SFAS No. 109, deferred assets and liabilities are recognized for the estimated future tax consequences between the financial statement carrying amounts of the existing assets and their respective basis. Deferred assets and liabilities are measured using enacted tax rates in effect for the year in which temporary differences are expected to be recovered or settled. Under SFAS No. 109 the effect on deferred assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. The Company has a net operating loss carry forward of $5,194 which is offset by a $5,194 valuation allowance due the uncertainty surrounding the ultimate realization of these assets. The loss carryforward expires in 2019. NOTE 5 NEW ACCOUNTING PRONOUCEMENTS In December 2002, the FASB issued Statements of Financial Accounting Standards No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure an Amendment of FASB Statement No. 123" (SFAS 148). SFAS 148 amends SFAS 123 "Accounting for Stock-Based Compensation," providing for an alternative method of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. Additionally, it amends the disclosure requirements of SFAS 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS 148 is effective for fiscal years beginning after December 15, 2002. The interim disclosure provisions are effective for financial reports containing financial statements for interim periods beginning after December 15, 2002. The Company's adoption of the interim disclosure provisions of SFAS 148 did not affect our financial position. The FASB issued FASB Interpretation No. 46, "Consolidation of Variable Interest Entities (FIN 46) in January 2003. FIN 46 requires that if an entity has a controlling financial interest in a variable interest entity, the assets, liabilities and results of activities of the variable interest entity should be included in the consolidated financial statements of the entity. This FASB is not applicable to the company since the company does not have any variable interest entities. F-7

USED KAR PARTS, INC. (A DEVELOPMENT STAGE COMPANY) NOTES TO FINANCIAL STATEMENTS JANUARY 31, 2004 NOTE 5 NEW ACCOUNTING PRONOUCEMENTS - continued In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity" (SFAS 150), sets standards for an issuer as to how to classify and measure financial instruments with characteristies of both liabilities and equity. SFAS 150 is effective for financial instruments entered into after May 31, 2003, and is effective after June 15, 2003. Adoption of SFAS 150 is not expected to have a material effect on the Company. NOTE 6 SUBSEQUENT EVENTS The Company is negotiating a possible requisition with the shareholders of a biotechology company. The terms of an agreement have not been finalized. F-8

ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. ITEM 8A. CONTROLS AND PROCEDURES Our Chief Executive Officer, based on evaluation of our disclosure controls and procedures (as defined in Rules 13a-5(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) required by paragraph (b) of Rule 13a-15 or Rule 15d-15, as of January 31, 2004, has concluded that our disclosure controls and procedures were effective to ensure the timely collection, evaluation and disclosure of information relating to our company that would potentially be subject to disclosure under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. There has been no significant change in our internal controls over financial reporting that could significantly affect internal controls subsequent to October 31, 2003. 10

PART III ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT The following table sets forth the names and ages of our current directors and executive officers, the principal offices and positions held by each person and the date such person became a director or executive officer. The executive officers are elected annually by the Board of Directors. The directors serve one-year terms until their successors are elected. The executive officers serve terms of one year or until their death, resignation or removal by the Board of Directors. There are no family relationships between any of the directors and executive officers. In addition, there was no arrangement or understanding between any executive officer and any other person pursuant to which any person was selected as an executive officer. Our directors and executive officers as of May 5, 2004, are as follows: Name Age Position ---- --- -------- Christoph Bruening 36 President, Secretary and Director Mr. Bruening was appointed director and President/Secretary of the Company on February 25, 2004 to fill the vacancy resulting from the resignation of Jeannine Karklins. Mr. Bruening serves as a Director of Callisto Pharmaceuticals, Inc., a biopharmaceutical company primarily focused on the development of drugs to treat multiple myeloma, other cancers and osteolytic bone disease. He organized Value Relations GmbH, a full service investor relations firm operating in Frankfurt, Germany in 1999 and currently serves as its Managing Partner. From 1998 to 1999, Mr. Bruening served as a funds manager and Director of Asset Management for Value management & Research AG, a private investment fund and funds manager in Germany. From 1997 to 1998, Mr. Bruening was a financial analyst and Head of Research for Value Research GmbH. Mr. Bruening is a member of the advisory board of Clarity AG and served as a member of the board of Matchnet plc. Mr. Bruening holds a Bachelor of Science degree in Chemistry from Technischen Universitat Darmstadt. COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Section 16(a) of the Securities Exchange Act of 1934 is not applicable to our officers, directors or persons who own more than ten percent of our common stock until we register a class of securities under Section 12 thereunder. ITEM 10. EXECUTIVE COMPENSATION We have not paid any compensation to executives since our inception. COMPENSATION OF DIRECTORS Directors were not separately compensated for their services in the year ended January 31, 2004. 11

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth, as of May 5, 2004, certain information with respect to our equity securities owned of record or beneficially by (i) each of our officers and directors; (ii) each person who owns beneficially more than 5% of each class of our outstanding equity securities; and (iii) all directors and executive officers as a group. The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership includes any shares as to which the selling stockholder has sole or shared voting power or investment power and also any shares that the selling stockholder has the right to acquire within 60 days. The actual number of shares of Common Stock issuable upon the conversion of the debentures is subject to adjustment depending on, among other factors, the number of shares outstanding at the time of conversion and could be materially less than the number estimated in the table. Beneficial Ownership Name of Beneficial Owner Shares Percentage - ------------------------ ------ ---------- Panetta Partners, Ltd. 1,980,012(1) 96% - -------------------- (1) Of the shares owned by Panetta Partners, Ltd., 1,520,000 are pledged to secure $295,000 of debt incurred to acquire the shares. ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Panetta Partners, our principal shareholder, bears substantially all of our operating expenses. 12

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits Exhibit No. Exhibit Description 2.1 Capital Stock Purchase Agreement between Panetta Partners, Ltd. and Jeannine Karklins dated February 24, 2004 (1) 3.1 Articles of Incorporation of the Company (2) 3.2 Bylaws of the Company (2) 4.1 Form of Stock Certificate, $.001 par value (2) 9. None 10 None 11. Statement re: computation of per share earnings. See Notes to Financial Statements 13. None 16 None 18. None 21. None 22. None 23. None 24. None 31.1 Certification of Chief Executive Officer of Periodic Report pursuant to Rule 13a-14a and Rule 14d-14(a). * 31.2 Certification of Chief Financial Officer of Periodic Report pursuant to Rule 13a-14a and Rule 15d-14(a). * 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. * 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. * - -------------------- (1) Incorporated by reference to the exhibits filed with the Company's Current Report on Form 8-K dated February 26, 2004. (2) Incorporated by reference to the exhibits filed with the Company's Form SB-2 Registration Statement, as amended, filed June 25, 2003. * Filed herewith (b) Reports on Form 8-K The following reports on Form 8-K were filed during the quarter ended January 31, 2004: None 13

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES Audit Fees. We incurred aggregate fees and expenses of approximately $6,250 from Baum & Co., P.A. for the 2004 fiscal year. Such fees were primarily for work completed for our annual audit and reviews of our Form 10-QSB's. Audit Related Fees. We did not incur any audit related fees or expenses for the 2004 fiscal year. Such fees were primarily for due diligence related to mergers and acquisitions and accounting consultations related to mergers and acquisitions. Tax Fees. We incurred no fees from Baum & Co., P.A. for the 2004 and 2003 fiscal years for professional services rendered for tax compliance, tax advice and tax planning. All Other Fees. We did not incur any other fees from Baum & Co., P.A. during fiscal 2004 or fiscal 2003. The Board of Directors, acting as the Audit Committee considered whether, and determined that, the auditor's provision of non-audit services was compatible with maintaining the auditor's independence. All of the services described above for fiscal year 2004 and 2003 were approved by the Board of Directors pursuant to its policies and procedures. We intend to continue using Baum & Co., P.A. solely for audit and audit-related services, tax consultation and tax compliance services, and, as needed, for due diligence in acquisitions. 14

SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: May 17, 2004 USED KAR PARTS, INC. By: /s/ Christoph Bruening ------------------------------ Christoph Bruening, President Pursuant to requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated: Signature Capacity Date --------- -------- ---- /s/ Christoph Bruening President, Secretary May 17, 2004 - -------------------------- and Director Christoph Bruening 15

Exhibit 31.1

                                  CERTIFICATION


         I, Christoph Bruening, certify that:

         1. I have reviewed this annual report on Form 10-KSB of Used Kar Parts,
Inc.;

         2. Based on my knowledge, this annual report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
annual report;

         3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respect the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report.

         4. The registrant's other certifying officers and I am responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a)       designed such disclosure controls and procedures to ensure
                  that material information relating to the registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this annual report is being prepared;

         b)       evaluated the effectiveness of the registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of this annual report (the "Evaluation Date");
                  and

         c)       presented in this annual report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date;

         5. The registrant's other certifying officers and I have disclosed,
based on our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's Board of Directors (or persons performing the
equivalent functions):

         a)       all significant deficiencies in the design or operation of
                  internal controls which could adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial data and have identified for the registrant's
                  auditors any material weaknesses in internal controls; and

         b)       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal controls; and

         6. The registrant's other certifying officers and I have indicated in
this annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.


May 17, 2004

/s/ Christoph Bruening
- -------------------------------------------------
Christoph Bruening, President
(Chief Executive Officer and Financial Officer)



Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the annual report of Used Kar Parts, Inc. (the
"Company") on Form 10-KSB for the year ending January 31, 2004 as filed with the
Securities and Exchange Commission on May 17, 2004 (the "Report"), I, Christoph
Bruening, Chief Executive and Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.



/s/ Christoph Breuning
- --------------------------------------
Christoph Bruening
Chief Executive and Financial Officer
May 17, 2004


A signed original of this certification has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.